Compare MNMD & IIIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNMD | IIIN |
|---|---|---|
| Founded | 2019 | 1953 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 960.2M | 609.9M |
| IPO Year | N/A | N/A |
| Metric | MNMD | IIIN |
|---|---|---|
| Price | $12.29 | $33.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $25.78 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 116.9K |
| Earning Date | 11-06-2025 | 01-15-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 112.14 |
| EPS | N/A | ★ 2.10 |
| Revenue | N/A | ★ $647,706,000.00 |
| Revenue This Year | N/A | $14.97 |
| Revenue Next Year | N/A | $7.00 |
| P/E Ratio | ★ N/A | $15.87 |
| Revenue Growth | N/A | ★ 22.39 |
| 52 Week Low | $4.70 | $22.49 |
| 52 Week High | $14.43 | $41.64 |
| Indicator | MNMD | IIIN |
|---|---|---|
| Relative Strength Index (RSI) | 51.07 | 57.36 |
| Support Level | $12.00 | $31.89 |
| Resistance Level | $13.02 | $33.68 |
| Average True Range (ATR) | 0.67 | 0.75 |
| MACD | -0.00 | 0.30 |
| Stochastic Oscillator | 26.67 | 76.62 |
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.